Account (3S,9R,10S,13R,14R,17R)-17-((R)-6-hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
- Catalog No. :
- ACDLYL797
- CAS No. :
- 61585-29-3
- Molecular Formula :
- C27H44O2
- Molecular Weight :
- 400.65
IUPAC Name:(3S,9R,10S,13R,14R,17R)-17-((R)-6-hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
![(3S,9R,10S,13R,14R,17R)-17-((R)-6-hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol structure diagram](/images/productimg/no-pic.svg)
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | (3S,9R,10S,13R,14R,17R)-17-((R)-6-hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
|---|---|
| IUPAC Name | (3S,9R,10S,13R,14R,17R)-17-((R)-6-hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
| Molecular Formula | C27H44O2 |
| Molecular Weight | 400.65 |
| SMILES | C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@@]4(C)[C@@H]3CC[C@]12C |
| InChI Key | JJFYNCJHSCTBPW-MKBCXXKJSA-N |
| Synonym | 25-HydroxyluMisterol3;IMpurity A of Calcifediol;(3S,9R,10S,13R,14R,17R)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol;9β,10α-cholesta-5,7-diene-3β,25-diol;Calcifediol EP Impurity A/9β,10α-cholesta-5,7- diene-3β,25-diol;Calcifediol Impurity 1（Calcifediol EP Impurity A）;Calcifediol EP Impurity A;Cholesta-5,7-diene-3,25-diol, (3β,9β,10α)- (9CI) |
| CAS No. | 61585-29-3 |
Synthetic Route by SureRoute
2. ACDLYL797 Molecular Building Block Synthetic Route
(3S,9S,10R,13R,14R,17R)-17-((R)-6-hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
(3S,9R,10S,13R,14R,17R)-17-((2R,5R,E)-5,6-Dimethylhept-3-en-2-yl)-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
(3S,9S,10R,13R,14R,17R)-10,13-Dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol